Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021   193,060      
Beginning balance at Dec. 31, 2021 $ 2,091,392 $ 1,931 $ 2,743,560 $ (651,083) $ (3,016)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (37,966)     (37,966)  
Other comprehensive loss 1,631       1,631
Share-based compensation 21,438   21,438    
Settlement of accrued compensation liabilities through the issuance of share-based compensation awards 505   505    
Ending balance (in shares) at Mar. 31, 2022   193,060      
Ending balance at Mar. 31, 2022 $ 2,077,000 $ 1,931 2,765,503 (689,049) (1,385)
Beginning balance (in shares) at Dec. 31, 2022 194,271 194,271      
Beginning balance at Dec. 31, 2022 $ 2,124,261 $ 1,943 2,784,416 (652,876) (9,222)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 27,460     27,460  
Other comprehensive loss 68       68
Share-based compensation $ 5,422   5,422    
Stock option exercises (in shares) 300 327      
Stock option exercises $ 3,456 $ 3 3,453    
Issuance of common shares in connection with the vesting of restricted stock units (in shares)   310      
Issuances of common shares in connection with the vesting of restricted stock units (102) $ 3 (105)    
Issuance of common stock in connection with a business acquisitions (in shares)   90      
Issuances of common stock in connection with business acquisitions $ 1,472 $ 1 1,471    
Ending balance (in shares) at Mar. 31, 2023 194,998 194,998      
Ending balance at Mar. 31, 2023 $ 2,162,037 $ 1,950 $ 2,794,657 $ (625,416) $ (9,154)